248 related articles for article (PubMed ID: 13334990)
1. [Constancy of the phenomenon of interference of mycetes with the antibacterial action of the new antibiotics].
DI BELLA A
Nuovi Ann Ig Microbiol; 1956; 7(1):65-70. PubMed ID: 13334990
[No Abstract] [Full Text] [Related]
2. [Unusual behavior of Escherichia coli and its filtrate in relation to the antibacterial action of tyrothricin].
DI BELLA A; ZULIANI F; MASONI S
Boll Ist Sieroter Milan; 1955; 34(9-10):598-602. PubMed ID: 13293244
[No Abstract] [Full Text] [Related]
3. [Antagonism of action in vitro of tyrothricin combined with other antibiotics on isolated bacteria or mixtures of Schizomycetes and various fungi].
DI BELLA A; MASONI S; ZULIANI F
Boll Ist Sieroter Milan; 1955; 34(9-10):603-8. PubMed ID: 13293245
[No Abstract] [Full Text] [Related]
4. [Fungicidal and antibacterial property of vitamin K5 (2-methyl-4-amino-1-naphthol HC1) combined with antibiotics. I. Antagonism and synergism in relation to Staphylococcus aureus, E. coli, B. pyocyaneum and Candida albicans].
MASONI S; ZULIANI F; NEPPI LEVI P
Arch Sci Biol (Bologna); 1956; 40(1):38-46. PubMed ID: 13314907
[No Abstract] [Full Text] [Related]
5. [Ultimate potentiation in the antibacterial and fungicidal action of chemotherapeutic agents combined with vitamin K5 (2-methyl-4-amino-1-naphthol HC1)].
ZULIANI F; MASONI S
Arch Sci Biol (Bologna); 1956; 40(1):58-65. PubMed ID: 13314909
[No Abstract] [Full Text] [Related]
6. [Fungicidal and antibacterial property of vitamin K5 (2-methyl-4-amino-1-naphthol HC1) combined with antibiotics. II. Antagonism and synergism in regard to mixed schizomycete and fungus infections: Staphylococcus aureus, E. coli, B. pyocyaneum and Candida albicans].
MASONI S; ZULIANI F; NEPPI LEVI P
Arch Sci Biol (Bologna); 1956; 40(1):47-57. PubMed ID: 13314908
[No Abstract] [Full Text] [Related]
7. A comparison of erythromycin with oleandomycin in combination with other antibiotics against hospital staphylococci.
ELLIOTT HJ; HALL WH
J Lab Clin Med; 1959 Mar; 53(3):364-75. PubMed ID: 13631321
[No Abstract] [Full Text] [Related]
8. [Resistance characteristics in hospital material, with special reference to staphylococcic and enterococcic sensitivity to erythromycin].
KYLIN O
Sven Lakartidn; 1956 Sep; 53(36):2259-67. PubMed ID: 13360709
[No Abstract] [Full Text] [Related]
9. In vitro sensitivity of erythromycin-resistant strains of staphylococci and enterococci to vancomycin and novobiocin.
SCHNEIERSON SS; AMSTERDAM D
Antibiot Chemother (Northfield); 1957 May; 7(5):251-4. PubMed ID: 24544426
[No Abstract] [Full Text] [Related]
10. Studies on the bacteriostatic activity of the phenazine derivatives in vitro.
KAWAKAMI Y; TAKAHASHI T; YABE J
J Antibiot (Tokyo); 1955 Apr; 8(2):51-6. PubMed ID: 13242480
[No Abstract] [Full Text] [Related]
11. Studies on the present resistance state of pathogenic microorganisms.
RITZERFELD W
Ann Univ Sarav Med; 1957; 5(2):192-204. PubMed ID: 13470607
[No Abstract] [Full Text] [Related]
12. [Studies on certain properties of bacteria adapted to colimycin].
SAZYKIN IuO
Antibiotiki (Mosc); 1958; 3(1):98-102. PubMed ID: 24544825
[No Abstract] [Full Text] [Related]
13. Origin of erythromycin-resistant strains of Micrococcus pyogenes in infections; bacteriophage types and in vitro resistance of cultures to antibiotics.
WISE RI; VOIGT AE; COLLIN MV; CRANNY CL
AMA Arch Intern Med; 1955 Mar; 95(3):419-26. PubMed ID: 14349420
[No Abstract] [Full Text] [Related]
14. [Effect of various fractions of E. coli culture filtrate in broth on the antibacterial power of tyrothricin].
GIBERTI A; MASONI S
Boll Ist Sieroter Milan; 1955; 34(11-12):695-8. PubMed ID: 13293255
[No Abstract] [Full Text] [Related]
15. [Comparative studies on the effect of d-cycloserine and cycloserineracemate on pathogenic microorganisms].
RITZERFELD W
Z Hyg Infektionskr; 1958; 145(3):209-20. PubMed ID: 13625797
[No Abstract] [Full Text] [Related]
16. Development of resistance and cross-resistance in vitro to erythromycin, carbomycin, spiramycin, oleandomycin and streptogramin.
FINLAND M; JONES WF; NICHOLS RL
Proc Soc Exp Biol Med; 1956 Nov; 93(2):388-93. PubMed ID: 13379520
[No Abstract] [Full Text] [Related]
17. [In vitro antagonism between erythromycin and spiramycin].
CHABBERT Y
Ann Inst Pasteur (Paris); 1956 Jun; 90(6):787-90. PubMed ID: 13340322
[No Abstract] [Full Text] [Related]
18. [Antibiotics and quaternary ammonium compounds; research in vitro on the effects of combined achromycin and bradosol on Staphylococcus aureus and Escherichia coli].
SCALA A; VICARI F
Riv Patol Clin; 1955 Dec; 10(12):685-94. PubMed ID: 13351463
[No Abstract] [Full Text] [Related]
19. Determination of the sensitivity of bacteria to combinations of antibiotics in vitro; discussion of some results, especially with the combination tetracyclin-erythromycin.
OSKAM HJ
Acta Med Scand; 1956 Oct; 155(5):335-51. PubMed ID: 13372188
[No Abstract] [Full Text] [Related]
20. The nature of polymyxin activity against a gram-positive organism.
RHODES RE; VILA OA; FERLAUTO RJ
Antibiot Chemother (Northfield); 1953 May; 3(5):509-12. PubMed ID: 24542416
[No Abstract] [Full Text] [Related]
[Next] [New Search]
